Clinical Trial Update: Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating hydroxychloroquine for primary thrombosis prevention in antiphospholipid antibody–positive patients was terminated, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Antiphospholipid Syndrome | Phase 3 | Status: TERMINATED | Results posted: 2021-05-04